Changsong Lin

500 total citations
37 papers, 365 citations indexed

About

Changsong Lin is a scholar working on Rheumatology, Molecular Biology and Hematology. According to data from OpenAlex, Changsong Lin has authored 37 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 10 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Changsong Lin's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (9 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Changsong Lin is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (9 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Changsong Lin collaborates with scholars based in China, United States and Taiwan. Changsong Lin's co-authors include Qiang Xu, Qingping Liu, Minying Liu, Yubao Jiang, Xiaobao Liu, Hanshi Xu, Zhenquan Wei, Nan Li, Mingying Zhang and Nan Li and has published in prestigious journals such as Diabetes, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Changsong Lin

35 papers receiving 361 citations

Peers

Changsong Lin
Javaid Alam Pakistan
Reza Alimohammadi Iran
Kang Zheng China
Ligang Jie China
Jingyu Chen China
Bin Dong China
Xiaoming Huang China
Huimin Ding China
Javaid Alam Pakistan
Changsong Lin
Citations per year, relative to Changsong Lin Changsong Lin (= 1×) peers Javaid Alam

Countries citing papers authored by Changsong Lin

Since Specialization
Citations

This map shows the geographic impact of Changsong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changsong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changsong Lin more than expected).

Fields of papers citing papers by Changsong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changsong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changsong Lin. The network helps show where Changsong Lin may publish in the future.

Co-authorship network of co-authors of Changsong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Changsong Lin. A scholar is included among the top collaborators of Changsong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changsong Lin. Changsong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yifang, Kaiqiang Li, Qiuping Wu, et al.. (2025). Neutrophil-to-albumin ratio: a novel predictor of osteoporosis in rheumatoid arthritis. Frontiers in Immunology. 16. 1666884–1666884.
2.
3.
Zhong, Xiaoqin, Lianjie Liu, Qingping Liu, et al.. (2024). Periplogenin inhibits pathologic synovial proliferation and infiltration in rheumatoid arthritis by regulating the JAK2/3-STAT3 pathway. International Immunopharmacology. 128. 111487–111487. 5 indexed citations
4.
Ma, Xiaona, et al.. (2024). Allopurinol is Associated with an Increased Risk of Cerebral Infarction: A Two-Sample Mendelian Randomization Study. ACS Omega. 9(31). 33826–33832. 1 indexed citations
5.
Ma, Xiaona, Shiow‐Ing Wang, Feng Wei, et al.. (2024). Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients. Frontiers in Pharmacology. 15. 1370661–1370661. 8 indexed citations
6.
Ma, Xiaona, et al.. (2024). Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and Therapy. 13(3). 715–725. 2 indexed citations
7.
Du, Ping, Wenyan Qin, Yiyi Hu, et al.. (2024). Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial. Complementary Therapies in Medicine. 82. 103037–103037. 3 indexed citations
8.
Xu, Qiang, Xiaobao Liu, Xiaona Ma, et al.. (2024). Kunduan Yimu Decoction affected Th17/Treg balance through microRNA-124 to improve rheumatoid arthritis pathology. Phytomedicine. 135. 156129–156129. 3 indexed citations
9.
Ma, Xiaona, Nan Li, Xiaoqin Zhong, et al.. (2023). Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway. Phytomedicine. 123. 155243–155243. 13 indexed citations
10.
Wang, Xiaodan, et al.. (2023). A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report. International Journal of Rheumatic Diseases. 26(7). 1417–1421. 11 indexed citations
11.
Zhong, Xiaoqin, et al.. (2023). The Underlying Mechanism of Duanteng Yimu Decoction in Inhibiting Synovial Hyperplasia in Rheumatoid Arthritis. Journal of Immunology Research. 2023. 1–11. 4 indexed citations
12.
Chen, Shulin, Qiang Xu, & Changsong Lin. (2023). Methotrexate is associated with decreased total thyroxine in patients with rheumatoid arthritis. Inflammopharmacology. 31(5). 2383–2392. 2 indexed citations
13.
Tang, Yujun, Haichang Li, Lin Huang, et al.. (2022). Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial. Frontiers in Pharmacology. 13. 793394–793394. 1 indexed citations
14.
Liu, Xiaobao, et al.. (2022). Case Report: A Promising Treatment Strategy for Noninfectious Uveitis. Frontiers in Pharmacology. 12. 784860–784860. 7 indexed citations
15.
Kuang, Yu, Ruiru Li, Jingnan Wang, et al.. (2021). Nitidine chloride inhibits fibroblast like synoviocytes-mediated rheumatoid synovial inflammation and joint destruction by targeting KCNH1. International Immunopharmacology. 101(Pt A). 108273–108273. 9 indexed citations
16.
Peng, Jie, Qing Ma, Changsong Lin, et al.. (2021). Intradermal acupuncture for rheumatoid arthritis: study protocol for a randomised controlled trial. Trials. 22(1). 450–450. 4 indexed citations
17.
Chen, Zhixin, et al.. (2021). Association between neutrophils and renal impairment of rheumatoid arthritis: A retrospective cross‐sectional study. Immunity Inflammation and Disease. 9(3). 1000–1008. 3 indexed citations
18.
19.
Li, Nan, Yanyan Liu, Qiang Xu, et al.. (2017). Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway. International Immunopharmacology. 55. 174–182. 100 indexed citations
20.
An, Yuan, Tian Liu, Dongyi He, et al.. (2016). The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study. Clinical Rheumatology. 36(1). 35–43. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javaid Alam Breakdown of academic impact, for papers by Reza Alimohammadi Breakdown of academic impact, for papers by Kang Zheng Breakdown of academic impact, for papers by Ligang Jie Breakdown of academic impact, for papers by Jingyu Chen Breakdown of academic impact, for papers by Bin Dong Breakdown of academic impact, for papers by Xiaoming Huang Breakdown of academic impact, for papers by Huimin Ding
Rankless by CCL
2026